Comparative safety and efficacy study of two atrophic rhinitis vaccines in gilts

Trang chủ Tri thức Comparative safety and efficacy study of two atrophic rhinitis vaccines in gilts

Comparative safety and efficacy study of two atrophic rhinitis vaccines in gilts

The aim of this study was to evaluate and compare the efficacy and safety of two commercially available vaccines for the prevention of atrophic rhinitis (AR) in swine by comparing the serological response and the body temperature increase after vaccination. RHINISENG® is a vaccine for the prevention of progressive and non-progressive AR in swine, which contains HIPRAMUNE® Gd as an adjuvant. The other commercial vaccine used in this study is based on dl-α-tocopherol and is only indicated against progressive AR.

Giới thiệu về bài báo này

Được đăng tại

ESPHM Congress, 2016

Tác giả

Acal, L.; Montané, J.; Camprodon, A.; Pedrazuela, R.; March, R.

Tóm tắt

The results obtained by RHINISENG® (group 1) showed a lower body temperature increase and a higher and more homogeneous humoral immune response against PMT after vaccination than the results obtained by its competitor (group 2) under field conditions.

Dịch vụ liên quan

Sản phẩm liên quan

Chia sẻ